{"id":"W4200357740","doi":"10.1007/s40744-021-00405-w","title":"Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib","year":2021,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Pfizer (Canada)","funders":"Celgene; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Tofacitinib; Discontinuation; Janus kinase inhibitor; Nausea; Adverse effect; Internal medicine; Placebo; Rheumatoid arthritis; Vomiting; Incidence (geometry); Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006311508,0.0003855276,0.002006792,0.001060371,0.0002978497,0.0006280222,0.0002529655,0.0004377842,0.001351064],"category_scores_gemma":[0.006494251,0.0002656081,0.004650848,0.001191563,0.0001790835,0.0005323506,0.0003320673,0.0008155929,0.00008498941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003637348,"about_ca_system_score_gemma":0.0004349069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005966452,"about_ca_topic_score_gemma":0.001384247,"domain_scores_codex":[0.9957682,0.001886216,0.0008965165,0.000458639,0.0007082951,0.0002822027],"domain_scores_gemma":[0.9891344,0.006029814,0.003558315,0.0003414051,0.0005119126,0.0004242842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06885682,0.0004494973,0.8673412,0.001401718,0.01278172,0.0004033889,0.0002158249,0.001028271,0.002880092,0.00006809798,0.0004055357,0.04416797],"study_design_scores_gemma":[0.001732475,0.008191963,0.9845542,0.00006618814,0.00298408,0.0006347161,0.00006064985,0.0005655863,0.000370758,0.00008535732,0.0007270146,0.00002696083],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880469,0.00943888,0.0004283468,0.00005397943,0.00002757108,0.0001729029,0.000982732,0.000009352297,0.0008393184],"genre_scores_gemma":[0.9975747,0.0009141822,0.0003031926,0.00006083703,0.00004853035,0.0001242512,0.0007427406,0.000003040181,0.0002285532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006311508,"threshold_uncertainty_score":0.03337884,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005117525276364914,"score_gpt":0.2183013215595229,"score_spread":0.213183796283158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}